A phase II study of irinotecan (Camptosar) in patients with advanced sarcomas.
Phase of Trial: Phase II
Latest Information Update: 02 Jan 2013
At a glance
- Drugs Irinotecan (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 30 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 30 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.